Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
NTI Announcements
NTI initiates First Clinical Site for…
NTI
NEUROTECH INTERNATIONAL LIMITED
Market sensitive
NTI initiates First Clinical Site for Phase 3 ASD Trial
Date and time
17 March 2026 at 8:32 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Health Care Equipment & Services
View on ASX
Open original PDF
NTI announcement history
Recent NTI announcements
Appointment of Executive Chairman
Becoming a substantial holder
Secondary Trading Notice
Application for quotation of securities - NTI
Proposed issue of securities - NTI
Proposed issue of securities - NTI